Pilot study of aprepitant effect on aldosterone secretion in diabetic patient (diabetes mellitus) with hypertension associated with low renin
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2017
At a glance
- Drugs Aprepitant (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms APHOS-02
- 21 Aug 2017 Status changed from not yet recruiting to recruiting.
- 28 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Jul 2019.
- 28 Jun 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Jul 2019.